CARE Ratings · NSE: CARERATING · BSE: 534804

Q4 FY24 results · Jan–Mar 2024

CARE Ratings reported revenue from operations of ₹90.15 crore (up 16.3% from Q4 FY23) and net profit of ₹24.55 crore (up 21.8% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations90.1577.51+16.3%78.68+14.6%
Other income10.2910.37−0.8%13.68−24.8%
Total income100.4487.88+14.3%92.36+8.7%
Profit before tax36.1934.09+6.2%33.96+6.6%
Net profit for the period24.5520.15+21.8%23.92+2.6%
Attributable to shareholders of the company24.0819.70+22.3%23.46+2.7%
EPS, basic (₹)8.076.60+22.2%7.88+2.4%
Net margin (%)27.226.030.4
Standalone · ₹ crore
ItemQ4 FY24Q4 FY23YoYQ3 FY24QoQ
Revenue from operations74.8068.05+9.9%66.68+12.2%
Other income13.6710.12+35.1%10.58+29.3%
Total income88.4778.17+13.2%77.26+14.5%
Profit before tax46.3035.15+31.7%31.73+45.9%
Net profit for the period34.8325.86+34.7%22.23+56.7%
EPS, basic (₹)11.678.71+34.0%7.47+56.3%
Net margin (%)46.638.033.3
Consolidated
Filed with BSE
11 May 2024, 11:07 IST
Board meeting
09 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
11 May 2024, 11:07 IST
Board meeting
09 May 2024
Period
01 Jan 2024 to 31 Mar 2024
Review status
Unaudited
Source
XBRL filing on BSE